Finding ways to identify people for early genetic therapies
Official title: Developing strategies to identify candidate individuals for early genetic therapies
Funded at Duke University · NIH-10980623 · Data updated 2026-11-12
This study is looking to make it easier for people to find out if they might benefit from genetic treatments before having a baby or during pregnancy, so they can get the right care sooner and improve their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | September 9, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $153,252 |
| NIH project number | 1K23HD113824-01A1 |
| Project ID | NIH-10980623 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals planning to conceive or those who are pregnant, particularly those with a family history of genetic disorders.
✕Less likely to help
Patients who are not planning to conceive or who are not pregnant may not receive any benefit from this research.
What this research studies
This research focuses on improving the identification of individuals who may benefit from early genetic therapies. It aims to enhance the process of genetic diagnosis either before conception or during pregnancy, which can lead to timely treatment options. By refining guidelines for preconception carrier screening and utilizing large biobanks, the study seeks to ensure that more individuals receive appropriate genetic testing. This could ultimately allow for earlier interventions that may improve health outcomes for affected individuals.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnoses and treatments for genetic conditions, improving health outcomes for patients.
How similar studies have gone: Previous research has shown promise in improving genetic screening processes, indicating that this approach could be effective.
Where this research is happening
-
Duke University
Durham, United States Active
Researchers
- Principal investigator: Cohen, Jennifer L — Duke University
- Study coordinator: Cohen, Jennifer L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.